Cited by 1,345BRCA gene mutations in cancerCancer Genomics and DiagnosticsGenomics and Rare Diseases

The DOI matches its Crossref record; 54 of the 56 references it cites were found in a registry or an index.

Germline Mutations in Predisposition Genes in Pediatric Cancer

Open access

Zhang, Jinghui, Walsh, Michael F., Wu, Gang, Edmonson, Michael N., Gruber, Tanja A., Easton, John, Hedges, Dale, Ma, Xiaotu, Zhou, Xin, Yergeau, Donald A., Wilkinson, Mark R., Vadodaria, Bhavin, Chen, Xiang, McGee, Rose B., Hines-Dowell, Stacy, Nuccio, Regina, Quinn, Emily, Shurtleff, Sheila A., Rusch, Michael, Patel, Aman, Becksfort, Jared B., Wang, Shuoguo, Weaver, Meaghann S., Ding, Li, Mardis, Elaine R., Wilson, Richard K., Gajjar, Amar, Ellison, David W., Pappo, Alberto S., Pui, Ching-Hon, Nichols, Kim E., Downing, James R.·2015·New England Journal of Medicine

DOI 10.1056/nejmoa1508054PMC PMC4734119

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The prevalence and spectrum of predisposing mutations among children and adolescents with cancer are largely unknown. Knowledge of such mutations may improve the understanding of tumorigenesis, direct patient care, and enable genetic counseling of patients and families. METHODS: In 1120 patients younger than 20 years of age, we sequenced the whole genomes (in 595 patients), whole exomes (in 456), or both (in 69). We analyzed the DNA sequences of 565 genes, including 60 that have been associated with autosomal dominant cancer-predisposition syndromes, for the presence of germline mutations. The pathogenicity of the mutations was determined by a panel of medical experts with the use of cancer-specific and locus-specific genetic databases, the medical literature, computational predictions, and second hits identified in the tumor genome. The same approach was used to analyze data from 966 persons who did not have known cancer in the 1000 Genomes Project, and a similar approach was used to analyze data from an autism study (from 515 persons with autism and 208 persons without autism). RESULTS: Mutations that were deemed to be pathogenic or probably pathogenic were identified in 95 patients with cancer (8.5%), as compared with 1.1% of the persons in the 1000 Genomes Project and 0.6% of the participants in the autism study. The most commonly mutated genes in the affected patients were TP53 (in 50 patients), APC (in 6), BRCA2 (in 6), NF1 (in 4), PMS2 (in 4), RB1 (in 3), and RUNX1 (in 3). A total of 18 additional patients had protein-truncating mutations in tumor-suppressor genes. Of the 58 patients with a predisposing mutation and available information on family history, 23 (40%) had a family history of cancer. CONCLUSIONS: Germline mutations in cancer-predisposing genes were identified in 8.5% of the children and adolescents with cancer. Family history did not predict the presence of an underlying predisposition syndrome in most patients. (Funded by the American Lebanese Syrian Associated Charities and the National Cancer Institute.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1508054

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Enhancements and modifications of primer design program Primer3
Kõressaar, T., & Remm, M. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm091 · Cited by 2,618
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,544
Principles and Practice of Pediatric Oncology
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-8-636_3 · Cited by 2,034
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596
Self-citation

Flagged first, then by citations

Show all 56 references

2 of the 56 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Lindor NM, 2008, J Natl Cancer Inst Monogr, 1
Meldrum C, 2011, Clin Biochem Rev, 32, 177
Armes JE, 1999, Cancer Res, 59, 2011

Sorted by citations

Items 101–200 of 1,000

Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)
Li, M. M., Chao, E., Esplin, E. D., Miller, D. T., Nathanson, K. L., Plon, S. E., Scheuner, M. T., & Stewart, D. R. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0783-8 · Cited by 101
Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening
Offit, K., Tkachuk, K. A., Stadler, Z. K., Walsh, M. F., Diaz-Zabala, H. J., Levin, J. D., Steinsnyder, Z., Ravichandran, V., Sharaf, R., Frey, M. K., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02010 · Cited by 98
Self-citation
From Tissue-Agnostic to N-of-One Therapies: (R)Evolution of the Precision Paradigm
Adashek, J. J., Subbiah, V., & Kurzrock, R. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.08.009 · Cited by 99
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML
Yang, F., Long, N., Anekpuritanang, T., Bottomly, D., Savage, J. C., Lee, T. L., Solis-Ruiz, J. M., Borate, U., Wilmot, B., Tognon, C. E., et al. (2021) · Blood · doi:10.1182/blood.2021011354 · Cited by 102
Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up
Baliakas, P., Tesi, B., Wartiovaara‐Kautto, U., Stray‐Pedersen, A., Friis, L. S., Dybedal, I., Hovland, R., Jahnukainen, K., Raaschou‐Jensen, K., Ljungman, P. T., et al. (2019) · HemaSphere · doi:10.1097/hs9.0000000000000321 · Cited by 98
An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing
Baumhoer, D., Amary, F. M., & Flanagan, A. M. (2018) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22699 · Cited by 96
Prevalence of Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines
Yap, T. A., Ashok, A., Stoll, J., Mauer, E. A., Nepomuceno, V. M., Blackwell, K., Garber, J. E., & Meric‐Bernstam, F. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.13070 · Cited by 96
Cancer Progress and Priorities: Childhood Cancer
Lupo, P. J., & Spector, L. G. (2020) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0941 · Cited by 91
Genetic predisposition and chromosome instability in neuroblastoma
Tonini, G. P., & Capasso, M. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09843-4 · Cited by 95
Precision medicine in pediatric oncology: Lessons learned and next steps
Mody, R. J., Prensner, J. R., Everett, J. N., Parsons, D. W., & Chinnaiyan, A. M. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26288 · Cited by 94
Genetic susceptibility to neuroblastoma
Tolbert, V. P., Coggins, G. E., & Maris, J. M. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.03.008 · Cited by 91
The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms
Li, P., Brown, S., Williams, M., White, T., Xie, W., Cui, W., Peker, D., Lei, L., Kunder, C. A., Wang, H., et al. (2022) · Blood · doi:10.1182/blood.2021015135 · Cited by 87
Genetic Predisposition to Neuroblastoma
Barr, E. K., & Applebaum, M. A. (2018) · Children · doi:10.3390/children5090119 · Cited by 90
Pediatric Rhabdomyosarcoma: Epidemiology and Genetic Susceptibility
Martin‐Giacalone, B. A., Weinstein, P. A., Plon, S. E., & Lupo, P. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10092028 · Cited by 84
Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents
Attarbaschi, A., Carraro, E., Abla, O., Barzilai-Birenboim, S., Bomken, S. N., Brugières, L., Bubanská, E., Burkhardt, B., Chiang, A., Csóka, M., et al. (2016) · Haematologica · doi:10.3324/haematol.2016.147116 · Cited by 84
Frequent inactivating germline mutations in DNA repair genes in patients with Ewing sarcoma
Brohl, A. S., Patidar, R., Turner, C., Wen, X., Song, Y., Wei, J. S., Calzone, K. A., & Khan, J. I. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.206 · Cited by 83
Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies
Findlay, I. J., Iuliis, G. N. D., Duchatel, R. J., Jackson, E. R., Vitanza, N. A., Cain, J. E., Waszak, S. M., & Dun, M. D. (2021) · Oncogene · doi:10.1038/s41388-021-02102-y · Cited by 86
Next Generation Sequencing and Pediatric Brain Tumors: Detection of Cancer Predisposition Syndromes in Patients and Their Families
Grund, K., Sturm, D., Sutter, C., Sahm, F., Hinderhofer, K., Kratz, C. P., Schrimpf, D., von Deimling, A., Pajtler, K. W., Jones, D., et al. (2017) · OBM Genetics · doi:10.21926/obm.genet.1704011 · Cited by 82
Expanding the spectrum of dicer1-associated sarcomas
Warren, M., Hiemenz, M., Schmidt, R. J., Shows, J. T., Cotter, J. A., Toll, S. A., Parham, D. M., Biegel, J. A., Mascarenhas, L., & Shah, R. (2019) · Modern Pathology · doi:10.1038/s41379-019-0366-x · Cited by 82
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
Jahn, A., Rump, A., Widmann, T. J., Heining, C., Horak, P., Hutter, B., Paramasivam, N., Uhrig, S., Gieldon, L., Drukewitz, S., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.07.008 · Cited by 87
TP53Mutations in Hypodiploid Acute Lymphoblastic LeukemiaPreprint
Comeaux, E. Q., & Mullighan, C. G. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026286 · Cited by 77
Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization
Hol, J. A., Kuiper, R. P., van Dijk, F., Waanders, E., van Peer, S. E., Koudijs, M. J., Bladergroen, R. S., van Reijmersdal, S. V., Morgado, L. M., Bliek, J., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02510 · Cited by 77
Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe
Hettmer, S., Linardic, C. M., Kelsey, A. M., Rudzinski, E. R., Vokuhl, C., Selfe, J., Ruhen, O., Shern, J. F., Khan, J. I., Kovach, A. R., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.05.036 · Cited by 80
Hereditary cancer syndromes
Имянитов, Е. Н., Kuligina, E. S., Соколенко, А. П., Suspitsin, E. N., Yanus, G. A., Iyevleva, A. G., Ivantsov, A. O., & Алексахина, С. Н. (2023) · World Journal of Clinical Oncology · doi:10.5306/wjco.v14.i2.40 · Cited by 82
Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working Group
Bomken, S. N., ten Bosch, J. V. D. W., Attarbaschi, A., Bacon, C. M., Borkhardt, A., Boztuǧ, K., Fischer, U., Hauck, F. H., Kuiper, R. P., Lammens, T., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02912 · Cited by 77
Drug resistance‐related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies
Chen, R., Wang, G., Zheng, Y., Hua, Y., & Cai, Z. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14064 · Cited by 77
Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia
Bloom, M., Maciaszek, J. L., Clark, M. E., Pui, C., & Nichols, K. E. (2019) · Expert Review of Hematology · doi:10.1080/17474086.2020.1685866 · Cited by 79
Self-citation
Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair–targeted therapies
Tlemsani, C., Takahashi, N., Pongor, L. S., Rajapakse, V. N., Tyagi, M. G., Wen, X., Fasaye, G., Schmidt, K. T., Desai, P. A., Kim, C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc7488 · Cited by 75
The global clonal complexity of the murine blood system declines throughout life and after serial transplantation
Ganuza, M., Hall, T., Finkelstein, D., Wang, Y., Chabot, A., Kang, G., Bi, W., Wu, G., & McKinney‐Freeman, S. (2019) · Blood · doi:10.1182/blood-2018-09-873059 · Cited by 73
Self-citation
Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors
Akhavanfard, S., Padmanabhan, R., Yehia, L., Cheng, F., & Eng, C. (2020) · Nature Communications · doi:10.1038/s41467-020-16067-1 · Cited by 71
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource
Smith, K. S., Xu, K., Mercer, K., Boop, F. A., Klimo, P., DeCupyere, M., Grenet, J. A., Robinson, S., Dunphy, P. S., Baker, S. J., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02171-5 · Cited by 69
Self-citation
Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1
Kumamoto, T., Yamazaki, F., Nakano, Y., Tamura, C., Tashiro, S., Hattori, H., Nakagawara, A., & Tsunematsu, Y. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-02011-w · Cited by 71
A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes
Scollon, S., Anglin, A. K., Thomas, M. H., Turner, J. T., & Schneider, K. W. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0077-8 · Cited by 72
Genetic susceptibility to neuroblastoma: current knowledge and future directions
Egolf, L. E., Randall, M. P., Bosse, K. R., & Diskin, S. J. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2820-3 · Cited by 73
Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework
Haas, O. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03136 · Cited by 70
Analyses of rare predisposing variants of lung cancer in 6,004 whole genomes in Chinese
Wang, C., Dai, J., Qin, N., Fan, J., Ma, H., Chen, C., An, M., Zhang, J., Yan, C., Gu, Y., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.08.013 · Cited by 70
Self-citation
High Yield of Pathogenic Germline Mutations Causative or Likely Causative of the Cancer Phenotype in Selected Children with Cancer
Diets, I. J., Waanders, E., Ligtenberg, M. J. L., van Bladel, D. A. G., Kamping, E. J., Hoogerbrugge, P. M., Hopman, S. M. J., Olderode-Berends, M. J. W., Gerkes, E. H., Koolen, D. A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1725 · Cited by 70
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)
Cole, K. A., Pal, S., Kudgus, R. A., Ijaz, H., Liu, X., Minard, C. G., Pawel, B., Maris, J. M., Haas-Kogan, D. A., Voss, S. D., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3470 · Cited by 69
Common genetic variants associated with telomere length confer risk for neuroblastoma and other childhood cancers
Walsh, K. M., Whitehead, T. P., de Smith, A. J., Smirnov, I. V., Park, M., Endicott, A. A., Francis, S. S., Codd, V., Samani, N. J., Metayer, C., et al. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw037 · Cited by 68
Genetic Predisposition to Solid Pediatric Cancers
Capasso, M., Montella, A., Tirelli, M., Maiorino, T., Cantalupo, S., & Iolascon, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.590033 · Cited by 68
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
Schwartz, J. R., Ma, J., Kamens, J. L., Westover, T., Walsh, M. P., Brady, S. W., Michael, J. R., Chen, X., Montefiori, L. E., Song, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21255-8 · Cited by 69
Self-citation
Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes
Whitworth, J., Smith, P., Martín, J., West, H. D., Luchetti, A., Rodger, F., Clark, G. R., Carss, K., Stephens, J. C., Stirrups, K. E., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.04.013 · Cited by 68
Relevance of Fusion Genes in Pediatric Cancers: Toward Precision Medicine
Dupain, C., Harttrampf, A. C., Urbinati, G., Geoerger, B., & Massaad-Massade, L. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.01.005 · Cited by 67
Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience
Marron, J. M., DuBois, S. G., Bender, J. G., Kim, A., Crompton, B. D., Meyer, S. C., Janeway, K. A., & Mack, J. W. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26137 · Cited by 70
Evolving Significance of Tumor-Normal Sequencing in Cancer Care
Mandelker, D. L., & Ceyhan‐Birsoy, O. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.11.006 · Cited by 67
Retroperitoneal Sarcomas: An Update on the Diagnostic Pathology Approach
Choi, J. H., & Ro, J. Y. (2020) · Diagnostics · doi:10.3390/diagnostics10090642 · Cited by 65
Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes
Walsh, M. F., Ritter, D., Kesserwan, C. A., Sonkin, D., Chakravarty, D., Chao, E., Ghosh, R., Kemel, Y. M., Wu, G., Lee, K., et al. (2018) · Human Mutation · doi:10.1002/humu.23640 · Cited by 63
Self-citation
Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis
Subbiah, V., & Kurzrock, R. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.02833 · Cited by 65
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma
He, C., Xu, K., Zhu, X., Dunphy, P. S., Gudenas, B. L., Lin, W., Twarog, N. R., Hover, L. D., Kwon, C.-H., Kasper, L. H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24168-8 · Cited by 67
Self-citation
Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes
Goudie, C., Witkowski, L., Cullinan, N. M., Reichman, L., Schiller, I., Tachdjian, M., Armstrong, L., Blood, K. A., Brossard, J., Brunga, L., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.4536 · Cited by 64
Self-citation
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer
Church, A. J., Corson, L., Kao, P., Imamović, A., Reidy, D., Doan, D., Kang, W., Pinto, N. R., Maese, L. D., Laetsch, T. W., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01856-6 · Cited by 67
Germline Mutations in Cancer Predisposition Genes are Frequent in Sporadic Sarcomas
Chan, S. H., Lim, W. K., Ishak, N. D. B., Li, S.-T., Goh, W. L., Tan, G. S., Lim, K. H., Teo, M. C. C., Young, C. C., Malik, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10333-x · Cited by 65
CVID-Associated Tumors: Czech Nationwide Study Focused on Epidemiology, Immunology, and Genetic Background in a Cohort of Patients With CVID
Králíčková, P., Milota, T., Litzman, J., Malkusová, I., Jilek, D., Petanová, J., Vydláková, J., Zimulová, A., Froňková, E., Svatoň, M., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03135 · Cited by 64
Pathogenic Germline Mutations in DNA Repair Genes in Combination With Cancer Treatment Exposures and Risk of Subsequent Neoplasms Among Long-Term Survivors of Childhood Cancer
Qin, N., Wang, Z., Liu, Q., Song, N., Wilson, C. L., Ehrhardt, M. J., Shelton, K., Easton, J. B., Mulder, H. L., Kennetz, D., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02760 · Cited by 64
Self-citation
Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma
DeSisto, J. A., Lucas, J. T., Xu, K., Donson, A. M., Lin, T., Sanford, B. L., Wu, G., Tran, Q. T., Hedges, D. J., Hsu, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25709-x · Cited by 65
Self-citation
Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program ‘iTHER’
Langenberg, K. P. S., Meister, M. T., Bakhuizen, J. J., Boer, J. M., van Eijkelenburg, N. K. A., Hulleman, E., Ilan, U., Looze, E. J., Dierselhuis, M. P., van der Lugt, J., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.09.001 · Cited by 70
United States Dietary Trends Since 1800: Lack of Association Between Saturated Fatty Acid Consumption and Non-communicable Diseases
Lee, J. H., Duster, M., Roberts, T. R., & Devinsky, O. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.748847 · Cited by 62
Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer
Lønning, P. E., Nikolaienko, O., Pan, K., Kurian, A. W., Eikesdal, H. P., Pettinger, M. B., Anderson, G. L., Prentice, R. L., Chlebowski, R. T., & Knappskog, S. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.3846 · Cited by 62
Robotic Surgery in Pediatric Oncology: Lessons Learned from the First 100 Tumors—A Nationwide Experience
Blanc, T., Meignan, P., Vinit, N., Ballouhey, Q., Pio, L., Capito, C., Harte, C., Vatta, F., Galmiche, L., Minard‐Colin, V., et al. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-10777-6 · Cited by 61
Current and Emerging Roles of Whole-Body MRI in Evaluation of Pediatric Cancer Patients
Gottumukkala, R. V., Gee, M. S., Hampilos, P. J., & Greer, M. C. (2019) · Radiographics · doi:10.1148/rg.2019180130 · Cited by 61
Comprehensive germline-genomic and clinical profiling in 160 unselected children and adolescents with cancer
Wagener, R., Taeubner, J., Walter, C., Yasin, L., Alzoubi, D., Bartenhagen, C., Attarbaschi, A., Classen, C.-F., Kontny, U., Hauer, J., et al. (2021) · European Journal of Human Genetics · doi:10.1038/s41431-021-00878-x · Cited by 57
Germline genetic variants in men with prostate cancer and one or more additional cancers
Pilie, P. G., Johnson, A., Hanson, K., Dayno, M., Kapron, A. L., Stoffel, E. M., & Cooney, K. A. (2017) · Cancer · doi:10.1002/cncr.30817 · Cited by 59
Pediatric cancer risk in association with birth defects: A systematic review
Johnson, K. J., Lee, J. M., Ahsan, K., Padda, H., Feng, Q., Partap, S., Fowler, S. A., & Druley, T. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181246 · Cited by 60
Metabolism and immunity in breast cancer
Zhang, D., Xu, X., & Ye, Q. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0793-6 · Cited by 58
Germline Variants That Affect Tumor Progression
Chatrath, A., Ratan, A., & Dutta, A. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.10.005 · Cited by 57
X-CNV: genome-wide prediction of the pathogenicity of copy number variations
Zhang, L., Shi, J., Ouyang, J., Zhang, R., Tao, Y., Yuan, D., Lv, C., Wang, R., Ning, B., Roberts, R. A., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00945-4 · Cited by 59
CharGer: clinical Characterization of Germline variants
Scott, A. D., Huang, K., Weerasinghe, A., Mashl, R. J., Gao, Q., Rodrigues, F. M., Wyczalkowski, M. A., & Ding, L. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty649 · Cited by 58
Self-citation
Clonal dynamics in osteosarcoma defined by RGB marking
Gambera, S., Abarrategi, A., González‐Camacho, F., Morales‐Molina, Á., Roma, J. M., Alfranca, A., & Garcı́a-Castro, J. (2018) · Nature Communications · doi:10.1038/s41467-018-06401-z · Cited by 56
Molecular Changes in Retinoblastoma beyond RB1: Findings from Next-Generation Sequencing
Francis, J. H., Richards, A. L., Mandelker, D. L., Berger, M. F., Walsh, M. F., Dunkel, I. J., Donoghue, M. T. A., & Abramson, D. H. (2021) · Cancers · doi:10.3390/cancers13010149 · Cited by 57
Self-citation
The BRCA2-MEILB2-BRME1 complex governs meiotic recombination and impairs the mitotic BRCA2-RAD51 function in cancer cells
Zhang, J., Gurusaran, M., Fujiwara, Y., Zhang, K., Echbarthi, M., Vorontsov, E. A., Guo, R., Pendlebury, D. F., Alam, I., Livera, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15954-x · Cited by 62
Self-citation
Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences
Waanders, E., Scheijen, B., Jongmans, M. C. J., Venselaar, H., van Reijmersdal, S. V., van Dijk, A. H. A., Pastorczak, A. K., Weren, R. D. A., van der Schoot, C. E., van de Vorst, M., et al. (2016) · Leukemia · doi:10.1038/leu.2016.277 · Cited by 61
Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer
Kratz, C. P., Smirnov, D., Autry, R. J., Jäger, N., Waszak, S. M., Großhennig, A., Berutti, R., Wendorff, M., Hainaut, P. L., Pfister, S. M., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac151 · Cited by 55
Radiation Therapy for Soft Tissue Sarcoma
Larrier, N., Czito, B. G., & Kirsch, D. G. (2016) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2016.05.012 · Cited by 55
Impact of somatic and germline mutations on the outcome of systemic mastocytosis
Muñoz‐González, J. I., Jara‐Acevedo, M., Álvarez‐Twöse, I., Merker, J. D., Teodósio, C., Hou, Y., Henriques, A., Roskin, K. M., Sánchez‐Muñoz, L., Tsai, A. G., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018020628 · Cited by 55
Therapeutic implications of germline genetic findings in cancer
Thavaneswaran, S., Rath, E. M., Tucker, K., Joshua, A. M., Hess, D., Pinese, M., Ballinger, M. L., & Thomas, D. M. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0179-3 · Cited by 56
The Landscape of Pediatric Precision Oncology: Program Design, Actionable Alterations, and Clinical Trial Development
Langenberg, K. P. S., Looze, E. J., & Molenaar, J. J. (2021) · Cancers · doi:10.3390/cancers13174324 · Cited by 61
Germ line mutations associated with leukemias
Porter, C. C. (2016) · Hematology · doi:10.1182/asheducation-2016.1.302 · Cited by 54
Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer
Singhal, D., Hahn, C. N., Feurstein, S. K., Wee, L. Y. A., Moma, L., Kutyna, M., Chhetri, R., Eshraghi, L., SCHREIBER, A. W., Feng, J., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01246-w · Cited by 54
Epidemiology, genetics and treatment of multiple myeloma and precursor diseases
Hemminki, K., Försti, A., Houlston, R. S., & Sud, A. (2021) · International Journal of Cancer · doi:10.1002/ijc.33762 · Cited by 61
Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?
Tawana, K., Drazer, M. W., & Churpek, J. E. (2018) · Leukemia · doi:10.1038/s41375-018-0051-y · Cited by 55
Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia
Heikamp, E., & Pui, C. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.07.039 · Cited by 51
Self-citation
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study
Kim, J., Gianferante, M., Karyadi, D. M., Hartley, S. W., Frone, M. N., Luo, W., Robison, L. L., Armstrong, G. T., Bhatia, S., Dean, M. C., et al. (2021) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkab007 · Cited by 52
Risk Factors for Childhood Leukemia: Radiation and Beyond
Schmidt, J.-A., Hornhardt, S., Erdmann, F., Sánchez-García, I., Fischer, U., Schüz, J., & Ziegelberger, G. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.805757 · Cited by 61
Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes
McReynolds, L. J., Rafati, M., Wang, Y., Ballew, B. J., Kim, J., Williams, V. V., Zhou, W., Hendricks, R. M., Dagnall, C. L., Freedman, N. D., et al. (2022) · Blood · doi:10.1182/blood.2022016508 · Cited by 52
Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits
Park, S., Supek, F., & Lehner, B. (2018) · Nature Communications · doi:10.1038/s41467-018-04900-7 · Cited by 52
Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes—Practice resource of the National Society of Genetic Counselors
Berliner, J. L., Cummings, S. A., Burnett, B. B., & Ricker, C. N. (2021) · Journal of Genetic Counseling · doi:10.1002/jgc4.1374 · Cited by 55
Prevalence and characteristics of genetic disease in adult kidney stone formers
Anderegg, M. A., Olinger, E. G., Bargagli, M., Geraghty, R. M., Taylor, L., Nater, A., Bruggmann, R., Sayer, J. A., Vogt, B., Schaller, A., et al. (2024) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae074 · Cited by 51
White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk
Lønning, P. E., Berge, E. O., Bjørnslett, M., Minsaas, L., Chrisanthar, R., Høberg‐Vetti, H., Dulary, C., Busato, F., Bjørneklett, S., Eriksen, C., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m17-0101 · Cited by 49
Precision medicine in pediatric oncology
Burdach, S. E. G., Westhoff, M., Steinhauser, M., & Debatin, K. (2018) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-018-0084-3 · Cited by 53
Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma
Negri, G. L., Grande, B. M., Delaidelli, A., El-Naggar, A. M., Cochrane, D. R., Lau, C. C., Triche, T. J., Moore, R. A., Jones, S. J. M., Montpetit, A., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5319 · Cited by 51
Genomics of adult and pediatric solid tumors.
Rahal, Z., Abdulhai, F., Kadara, H. N., & Saab, R. H. (2018) · Europe PMC (PubMed Central) · Cited by 52
Toward prevention of childhood ALL by early-life immune training
Hauer, J., Fischer, U., & Borkhardt, A. (2021) · Blood · doi:10.1182/blood.2020009895 · Cited by 54
Cancer Genetic Counseling—Current Practice and Future ChallengesPreprint
Schienda, J., & Stopfer, J. E. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036541 · Cited by 55
Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study
Ghazani, A. A., Oliver, N. M., Pierre, J. P. S., Garofalo, A., Rainville, I. R., Hiller, E. H., Treacy, D. J., Rojas‐Rudilla, V., Wood, S., Bair, E. F., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.191 · Cited by 50
Heritable defects in telomere and mitotic function selectively predispose to sarcomas
Ballinger, M. L., Pattnaik, S., Mundra, P. A., Zaheed, M., Rath, E. M., Priestley, P., Baber, J., Ray-Coquard, I. L., Isambert, N., Causeret, S., et al. (2023) · Science · doi:10.1126/science.abj4784 · Cited by 49
Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results
Bradbury, A. R., Patrick‐Miller, L. J., Egleston, B. L., Hall, M. J., Domchek, S. M., Daly, M. B., Ganschow, P. S., Grana, G., Olopade, O. I., Fetzer, D., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy015 · Cited by 50
Penetrance and Expressivity in Inherited Cancer Predisposing Syndromes
Taeubner, J., Wieczorek, D., Yasin, L., Brozou, T., Borkhardt, A., & Kuhlen, M. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.09.002 · Cited by 56
Systematic Review of the Current Status of Human Sarcoma Cell Lines
Hattori, E., Oyama, R., & Kondo, T. (2019) · Cells · doi:10.3390/cells8020157 · Cited by 50
Assessment of Cancer Predisposition Syndromes in a National Cohort of Children With a Neoplasm
Bakhuizen, J. J., Hopman, S. M. J., Bosscha, M. I., Dommering, C. J., van den Heuvel‐Eibrink, M. M., Hol, J. A., Kester, L. A., Koudijs, M. J., Langenberg, K. P. S., Loeffen, J. L. C., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.54157 · Cited by 49
Dynamics of Age- versus Therapy-Related Clonal Hematopoiesis in Long-term Survivors of Pediatric Cancer
Hagiwara, K., Natarajan, S., Wang, Z., Zubair, H., Mulder, H. L., Dong, L., Plyler, E. M., Thimmaiah, P., Ma, X., Ness, K. K., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0956 · Cited by 50
Self-citation

Authors: Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., Wilkinson, M. R., Vadodaria, B., Chen, X., McGee, R. B., Hines-Dowell, S., Nuccio, R., Quinn, E., Shurtleff, S. A., Rusch, M., Patel, A., Becksfort, J. B., Wang, S., Weaver, M. S., Ding, L., Mardis, E. R., Wilson, R. K., Gajjar, A., Ellison, D. W., Pappo, A. S., Pui, C.-H., Nichols, K. E., & Downing, J. R.
Affiliations: St. Jude Children's Research Hospital (US)
Washington University in St. Louis (US)
ORCID: Zhang, Jinghui
Walsh, Michael F.
Wu, Gang
Edmonson, Michael N.
Gruber, Tanja A.
Easton, John
Ma, Xiaotu
Zhou, Xin
Yergeau, Donald A.
Wilkinson, Mark R.
Chen, Xiang
McGee, Rose B.
Nuccio, Regina
Quinn, Emily
Rusch, Michael
Patel, Aman
Becksfort, Jared B.
Weaver, Meaghann S.
Ding, Li
Mardis, Elaine R.
Wilson, Richard K.
Gajjar, Amar
Ellison, David W.
Pappo, Alberto S.
Pui, Ching-Hon
Nichols, Kim E.
Downing, James R.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2015-12-10
Volume: 373
Issue: 24
Pages: 2336-2346
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1508054
PMC: PMC4734119
OpenAlex: W2303408208
Cited by: 1,345
References: 56
Citations by year: 2026: 90 · 2025: 113 · 2024: 151 · 2023: 132 · 2022: 134 · 2021: 161 · 2020: 141 · 2019: 122 · 2018: 113 · 2017: 101 · 2016: 76 · 2015: 5
FWCI: 67.59
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
Funders: St. Jude Children's Research Hospital (CA21765)
American Lebanese Syrian Associated Charities (CA 21765)
National Cancer Institute (R01CA180006, CA21765, P30CA021765)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords: germline mutations, cancer susceptibility genes, childhood cancer, children and adolescents, TP53, APC, BRCA2, neurofibromatosis type 1, PMS2, RB1, RUNX1, tumor suppressor, pathogenicity assessment, family history of cancer, genetic counseling, autism spectrum disorder
MeSH terms: Adolescent, Autistic Disorder, Child, Female, Genes, Dominant, Humans, Male, Neoplasms, Genome, Human, Sequence Analysis, DNA, Germ-Line Mutation, SEER Program, Genetic Predisposition to Disease, Genes, Neoplasm, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Germline Mutations in Predisposition Genes in Pediatric Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks